Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor.

Kolenda T, Rutkowski P, Michalak M, Kozak K, Guglas K, Ryś M, Galus Ł, Woźniak S, Ługowska I, Gos A, Teresiak A, Mackiewicz A, Lamperska K, Mackiewicz J.

Oncotarget. 2019 Jun 11;10(39):3879-3893. doi: 10.18632/oncotarget.26989. eCollection 2019 Jun 11.

2.

Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.

Kolenda T, Guglas K, Kopczyńska M, Teresiak A, Bliźniak R, Mackiewicz A, Lamperska K, Mackiewicz J.

Cells. 2019 Apr 21;8(4). pii: E366. doi: 10.3390/cells8040366.

3.

EGOT lncRNA in head and neck squamous cell carcinomas.

Kolenda T, Kopczyńska M, Guglas K, Teresiak A, Bliźniak R, Łasińska I, Mackiewicz J, Lamperska K.

Pol J Pathol. 2018;69(4):356-365. doi: 10.5114/pjp.2018.81695.

4.

Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcome.

Kolenda T, Guglas K, Teresiak A, Bliźniak R, Lamperska K.

J Biomed Sci. 2019 Feb 13;26(1):17. doi: 10.1186/s12929-019-0511-3.

5.

lncRNA Expression after Irradiation and Chemoexposure of HNSCC Cell Lines.

Guglas K, Kolenda T, Teresiak A, Kopczyńska M, Łasińska I, Mackiewicz J, Mackiewicz A, Lamperska K.

Noncoding RNA. 2018 Nov 14;4(4). pii: E33. doi: 10.3390/ncrna4040033.

6.

Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.

Łasińska I, Kolenda T, Teresiak A, Lamperska KM, Galus Ł, Mackiewicz J.

Anticancer Agents Med Chem. 2019;19(3):290-303. doi: 10.2174/1871520618666180910092356.

PMID:
30198439
7.

2D and 3D cell cultures - a comparison of different types of cancer cell cultures.

Kapałczyńska M, Kolenda T, Przybyła W, Zajączkowska M, Teresiak A, Filas V, Ibbs M, Bliźniak R, Łuczewski Ł, Lamperska K.

Arch Med Sci. 2018 Jun;14(4):910-919. doi: 10.5114/aoms.2016.63743. Epub 2016 Nov 18.

8.

Tumor microenvironment - Unknown niche with powerful therapeutic potential.

Kolenda T, Przybyła W, Kapałczyńska M, Teresiak A, Zajączkowska M, Bliźniak R, Lamperska KM.

Rep Pract Oncol Radiother. 2018 May-Jun;23(3):143-153. doi: 10.1016/j.rpor.2018.01.004. Epub 2018 Mar 17. Review.

9.

lncRNA in HNSCC: challenges and potential.

Guglas K, Bogaczyńska M, Kolenda T, Ryś M, Teresiak A, Bliźniak R, Łasińska I, Mackiewicz J, Lamperska K.

Contemp Oncol (Pozn). 2017;21(4):259-266. doi: 10.5114/wo.2017.72382. Epub 2017 Dec 30. Review.

10.

Biological role of long non-coding RNA in head and neck cancers.

Kolenda T, Guglas K, Ryś M, Bogaczyńska M, Teresiak A, Bliźniak R, Łasińska I, Mackiewicz J, Lamperska KM.

Rep Pract Oncol Radiother. 2017 Sep-Oct;22(5):378-388. doi: 10.1016/j.rpor.2017.07.001. Epub 2017 Aug 1. Review.

11.

Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics.

Lamperska KM, Kolenda T, Teresiak A, Kowalik A, Kruszyna-Mochalska M, Jackowiak W, Bliźniak R, Przybyła W, Kapałczyńska M, Kozlowski P.

PLoS One. 2017 Jun 30;12(6):e0180265. doi: 10.1371/journal.pone.0180265. eCollection 2017.

12.

Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients.

Przybyła A, Lamperska K, Mackiewicz A.

Contemp Oncol (Pozn). 2015;19(4):276-9. doi: 10.5114/wo.2015.54227. Epub 2015 Sep 28.

13.

Unpredictable changes of selected miRNA in expression profile of HNSCC.

Lamperska KM, Kozlowski P, Kolenda T, Teresiak A, Blizniak R, Przybyla W, Masternak MM, Golusinski P, Golusinski W.

Cancer Biomark. 2016;16(1):55-64. doi: 10.3233/CBM-150540.

PMID:
26484611
14.

Circulating small non-coding RNA signature in head and neck squamous cell carcinoma.

Victoria Martinez B, Dhahbi JM, Nunez Lopez YO, Lamperska K, Golusinski P, Luczewski L, Kolenda T, Atamna H, Spindler SR, Golusinski W, Masternak MM.

Oncotarget. 2015 Aug 7;6(22):19246-63.

15.

Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence.

Zhi X, Lamperska K, Golusinski P, Schork NJ, Luczewski L, Kolenda T, Golusinski W, Masternak MM.

Oncotarget. 2015 Jan 1;6(1):547-55.

16.

The mystery of let-7d - a small RNA with great power.

Kolenda T, Przybyła W, Teresiak A, Mackiewicz A, Lamperska KM.

Contemp Oncol (Pozn). 2014;18(5):293-301. doi: 10.5114/wo.2014.44467. Epub 2014 Nov 5. Review.

17.

The anti-cancer actions of O6-methylguanine-DNA-methyltransferase in relation to colon polyps.

Kycler W, Korski K, Loziński C, Teresiak-Mańczak A, Przybyła A, Mackiewicz A, Cybulski Z, Lamperska K.

Pharmacol Rep. 2014 Dec;66(6):1060-4. doi: 10.1016/j.pharep.2014.06.019. Epub 2014 Jul 8.

PMID:
25443735
18.

Expression levels of insulin-like growth factors 1 and 2 in head and neck squamous cell carcinoma.

Zhi X, Lamperska K, Golusinski P, Schork NJ, Luczewski L, Golusinski W, Masternak MM.

Growth Horm IGF Res. 2014 Aug;24(4):137-41. doi: 10.1016/j.ghir.2014.04.003. Epub 2014 Apr 22.

19.

Development of a new, simple and cost-effective diagnostic tool for genetic screening of hereditary colorectal cancer--the DNA microarray assay.

Stojcev Z, Banasiewicz T, Kaszuba M, Sikorski A, Szczepkowski M, Bobkiewicz A, Paszkowski J, Krokowicz Ł, Biczysko M, Szmeja J, Jurkowska M, Majewski P, Mackiewicz A, Lamperska K, Drews M, Wojciechowicz J.

Acta Biochim Pol. 2013;60(2):195-8. Epub 2013 Jun 6.

20.

Analysis of O6-methylguanine-DNA methyltransferase methylation status in sporadic colon polyps.

Kycler W, Szarzyńska B, Loziński C, Korski K, Lamperska K.

Rep Pract Oncol Radiother. 2012 Jan 23;17(1):13-8. doi: 10.1016/j.rpor.2011.11.002. eCollection 2012.

Supplemental Content

Loading ...
Support Center